Young and middleaged people with longterm smoking, staying up late, and high mental stress, as well as patients with hypertension, diabetes, and hyperlipidemia, are all highrisk groups for sudden cardiac death.In addition to controlling “three highs,” quitting smoking, limiting alcohol, and maintaining regular routines, regular physical examinations can detect problems early for timely intervention. Electrocardiogram, echocardiography, and Holter monitor are basic tools fo

Unlike CAR-T therapy which is mainly concentrated in hematologic malignancies, NK cell therapy has broader application scenarios. It not only shows good prospects in the treatment of solid tumors such as lung cancer, liver cancer and colorectal cancer, but also has potential value in autoimmune diseases, neurological diseases and other fields, making up for the shortcomings of existing treatment methods.

NK cells can precisely identify abnormal hyperplastic cells in the thyroid, inhibit continuous nodule growth, secrete various cytokines, regulate local immune balance in the thyroid, relieve chronic inflammation, and block the formation and progression of nodules fundamentally.

Current research and clinical data demonstrate that NK cell therapy, with its advantages of high specificity, high safety and no obvious adverse reactions, has become a new direction for liver cancer treatment. It shows irreplaceable value especially in the treatment of intermediate and advanced liver cancer and liver cancer with high postoperative recurrence risk.

Opens a New Solution PathIn Ms. Liu’s case, 3 billion “trained” NK cells entered her body, likely precisely identifying and clearing cells causing inflammation and abnormal proliferation, and remodeling the immune microenvironment. They not only greatly reduced the solid nodule but also eliminated the premenstrual pain that had troubled her for years. This treatment model, based on activating the body’s own immune function, breaks the traditional binary choice of “surgery or

This article presents the diagnosis and treatment course of a 67-year-old female patient with ES-SCLC. Through two MDT discussions and based on the latest clinical research evidence, an individualized regimen of “first-line immunotherapy + chemotherapy + anti-angiogenesis therapy → local radiotherapy → combined maintenance therapy” was formulated. The patient finally achieved stable disease and symptom relief.providing practical reference for the diagnosis and treatment of ES

The recovery time after intramedullary nail fixation mainly depends on the speed of bone healing, generally taking 3–6 months. Postoperatively, intensive care of the injured site is required. During bone recovery, patients can take bone healing-aiding drugs as prescribed by doctors

As a common high-incidence cancer unique to men, prostate cancer often develops silently to an advanced stage without obvious symptoms. When many prostate cancer patients seek medical treatment, they not only focus on the treatment method itself but also worry about whether the treatment process and subsequent recovery will bring inconvenience and embarrassment to their lives and work. So, is there a non-invasive way to effectively treat prostate cancer?

The orthopedic team has successfully performed minimally invasive posterior intermuscular approach internal fixation surgery for the upper cervical spine, which is one of the most minimally invasive upper cervical spine technologies in the world. It can greatly reduce intraoperative muscle damage and blood loss, allowing patients to get out of bed and move around soon after the operation.

Precision Treatment Becomes a New Trend Mr. Jiang’s case is a microcosm of the Department of Cardiology at Shulan Hospital exploring precision treatment for cardiovascular diseases. In recent years, with the development of medical technology, the treatment of cardiovascular diseases has evolved from traditional "symptomatic treatment" to the "targeted treatment era," bringing new hope to more patients.

Minimally invasive surgery For Lung Cancer has achieved major breakthroughs. Assisted by thoracoscopy, it only requires a small incision of 3 cm. It reduces the need for blood transfusion—95% of patients do not require transfusion. The operation time is shortened to within 2 hours, and the hospital stay is reduced from two weeks to one week. It improves the radicality of the surgery, increasing the 5-year survival rate by 6% and significantly enhancing the quality of life.

After Varian launched HyperSight and it was implemented clinically, how did opinions from the frontlines change? If you ask a radiologist: "Can I use HyperSight to replace the department’s 256-slice CT for hospital-wide cardiac coronary angiography screening?" Answer: No need. Physical structure dictates high-end spiral CT’s dominance in ultimate SNR. However, in the context of tumor diagnosis, this gap is clinically imperceptible.

On September 25, the research team led by Shen Zhongyang and Wang Shusen from Tianjin First Central Hospital, together with Deng Hongkui's team from Peking University/Changping Laboratory, published a landmark paper in the top journal Cell. For the first time globally, they achieved clinical functional cure of type 1 diabetes through innovative stem cell-derived islet transplantation. The patient no longer required exogenous insulin therapy during the 1-year follow-up period.

Driven by continued Chinese innovation, robust market demand, and industrial upgrades, the DBS industry is poised for a significant development period. It is expected that China will play an increasingly pivotal role in the field of neuro-modulation, offering more "Chinese Solutions" to global neurological disorder patients in the years to come.

Early-stage, radiation-sensitive tumors: Curative radiation (goal: cure). · Need to shrink tumors preoperatively or eliminate residuals postoperatively: Adjuvant radiation (goal: prevent recurrence). · Advanced cancer with severe pain, bleeding, or compression: Palliative radiation (goal: reduce suffering). Radiation therapy is personalized. Consult doctors/medical physicists for tailored plans to avoid detours.

The procedure was performed percutaneously under DSA and ICE guidance. Post-procedure ultrasound confirmed the bioabsorbable PFO occluder had good morphology and position, complete closure with no residual shunt, no pericardial effusion, and no adverse reactions before or after closure, indicating successful closure.

We are honored to announce that HANGZHOU MEDTOURCHINA TECHNOLOGY CO., LTD has been officially admitted as a BLUE Member of the Health Tourism Development Center of Islamic Countries (HTDC)! 🌍

We’re delighted to announce that MedTourChina has officially signed a Framework Strategic Cooperation Agreement with Healtra, a doctor-led healthcare cooperation. This partnership marks the beginning of a new phase of collaboration between China and the GCC region, focusing on knowledge exchange, medical coordination, and healthcare innovation.